Home Your basket
• Antro choanal polyp in ch...
   Price 10.00 €
• Somatic tinnitus (review)...
   Price 12.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Description of complicati...
   Price 5.50 €
• Rhinitis and allergy test...
   Price 8.50 €
• Schwannomas of the neck. ...
   Price 5.50 €
• Mastoid eosinophilic gran...
   Price 5.50 €
• Congenital cholesteatoma ...
   Price 5.50 €
• Cephalic vein access for ...
   Price 10.50 €
• Artistic anatomy of the n...
   Price 8.50 €
• Seven cases of inverted n...
   Price 10.50 €
• Cholesteatoma by osteoma ...
   Price 8.50 €
• Benign paroxysmal positio...
   Price 5.50 €
• Usher type I syndrome in ...
   Price 10.50 €
• Role of positron emission...
   Price 15.00 €
• Cottle's technique septop...
   Price 5.50 €
• Stuttering of the “Miror”...
   Price 5.50 €
• The Voice Handicap Index:...
   Price 10.50 €
• Delayed facial palsy afte...
   Price 8.50 €
• A schwannoma of the hypog...
   Price 8.50 €
• Mast cells in chronic inf...
   Price 10.50 €
• Preliminary experimental ...
   Price 10.50 €
• Multiple intracranial epi...
   Price 14.00 €
• DROP ATTACKS revealed a ...
   Price 10.00 €
• Sinonasal malignant melan...
   Price 5.50 €
• Ossiculoplasty with hydro...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Thyroid pseudo-nodules: 3...
   Price 5.50 €
• Prognostic value of senti...
   Price 10.50 €
• Thyroid oncocytomas....
   Price 10.50 €
• Voice related quality of ...
   Price 10.50 €
• Otomycosis: Clinical and ...
   Price 5.50 €
• Treatment of acute mastoi...
   Price 8.50 €
• Tuberculosis of the laryn...
   Price 5.50 €
• Treatments of hereditary ...
   Price 10.50 €
• Salvage composite resecti...
   Price 10.50 €
• Cosmetic radiofrequency...
   Price 10.50 €

Total Order 320.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 3 - 2006 o

OTOLOGY

Amphicrine adenoma of the middle ear: Three cases reports and a review of the literature


Authors : K. Aubry, J. P. Sauvage, S. Puyraud (Limoges)

Ref. : Rev Laryngol Otol Rhinol. 2006;127,3:145-149.

Article published in french
Downloadable PDF document french



Summary : Amphicrine adenoma is an extremely rare tumor of the middle ear. We report three cases obtained over a twenty year period. The aim of this study is to discuss our clinical cases and review the literature. Materials and methods: Three cases of middle ear amphicrine tumour were reviewed. Results: During a 10 year period (1986-2006) three cases of middle ear amphicrine tumour were treated at our unit (2 male, 1 female). The presenting complaint was hearing loss in all 3 cases. Amphicrine adenoma is diagnosed by an immuno-histological examination of pathological specimens. Differential diagnosis can be difficult and one individual was initially treated as an adenocarcinoma by radiotherapy. This patient succumbed to cerebral mycosis two years post-radiotherapy. The other two patients have no evidence of recurrence eight and nine years post treatment. Conclusion: Historically, differential diagnosis between amphicrine adenoma and adenocarcinoma of the middle ear has been very difficult. Carcinoid tumour is considered to be a more agressive form of amphicrine adenoma. Tumour progression is through loco regional invasion. Complete excision by surgical management with long term follow up is the treatment of choice.

Price : 8.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE